Condor Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-16,250
Closed -$164K 208
2023
Q1
$164K Buy
+16,250
New +$164K 0.02% 174

Other funds holding DALS

Condor Capital Management's DALS Position: Q2 2023 in Review

Condor Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q2 2023, closing a stake of 16,250 shares — an estimated $164K sold.

Condor Capital Management first reported a position in DALS in Q1 2023 and held it in 1 quarter. The position peaked at $164K in Q1 2023. 50 funds tracked by Wall St. Rank hold DALS as of Q2 2023.

  • Condor Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Condor Capital Management sold 16,250 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $164K.
  • Condor Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 1 quarter.
  • Condor Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $164K in Q1 2023.
  • 50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Condor Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.